Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Rating of “Hold” by Analysts

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received an average recommendation of “Hold” from the six research firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have assigned a buy recommendation to the company.

Several brokerages have issued reports on SAUHY. Barclays reissued an “overweight” rating on shares of Straumann in a research note on Thursday. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Tuesday, April 14th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday, April 23rd.

Straumann Price Performance

SAUHY stock traded up $0.55 during mid-day trading on Thursday, reaching $13.30. 11,224 shares of the stock traded hands, compared to its average volume of 168,536. Straumann has a 52-week low of $9.44 and a 52-week high of $14.11. The stock’s fifty day moving average is $11.25 and its 200-day moving average is $11.48.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.